Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells (Q44225910)
scientific article
Language:
Current Data About Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells
(P31) (Q13442814)
(P248)
(P698) 12446442
(P813) Friday, December 1, 2017

(P304) 3236-3239
(P248)
(P698) 12446442
(P813) Friday, December 1, 2017

(P407) (Q1860)

(P433) 8
(P248)
(P698) 12446442
(P813) Friday, December 1, 2017

(P478) 101
(P248)
(P698) 12446442
(P813) Friday, December 1, 2017

(P577) Thursday, November 21, 2002
(P248)
(P698) 12446442
(P813) Friday, December 1, 2017

(P921) (Q29496)
(P887)

(Q976388)
(P887)

(P1433) (Q885070)
(P248)
(P698) 12446442
(P813) Friday, December 1, 2017

(P1476) "Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells" (language: en)
(P248)
(P698) 12446442
(P813) Friday, December 1, 2017

(P2093) Ramadevi Nimmanapalli
(P1545) 1
(P248)
(P698) 12446442
(P813) Friday, December 1, 2017

Lianne Fuino
(P1545) 2
(P248)
(P698) 12446442
(P813) Friday, December 1, 2017

Corinne Stobaugh
(P1545) 3
(P248)
(P698) 12446442
(P813) Friday, December 1, 2017

Victoria Richon
(P1545) 4
(P248)
(P698) 12446442
(P813) Friday, December 1, 2017

Kapil Bhalla
(P1545) 5
(P248)
(P698) 12446442
(P813) Friday, December 1, 2017

other details
description scientific article

External Links
(P356) 10.1182/BLOOD-2002-08-2675
(P698) 12446442
(P5875) 11023384